This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Sino Biological
product type :
protein
product name :
Cynomolgus BTC / Betacellulin Protein (Fc Tag)
catalog :
90033-C02H
quantity :
100µg
price :
348 USD
product information
Note :
Online
Catalog Number :
90033-C02H
Product Name :
Cynomolgus BTC / Betacellulin Protein (Fc Tag)
Product Type :
Protein
Host Species :
HEK293 Cells
Conjugation :
C-human IgG1-Fc
Size :
100µg
List Price :
348 USD
Gene ID :
XP_001101880.1
Product Description :
A DNA sequence encoding the cynomolgus BTC (XP_001101880.1) (Met1-Tyr111) was expressed with the Fc region of human IgG1 at the C-terminus.
SpeciesSummary :
Cynomolgus
ALTnames :
BTC
Purity :
> 85 % as determined by SDS-PAGE
Buffer :
Lyophilized from sterile PBS, pH 7.4.
Packaging :
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Storage :
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
company information

Sino Biological
Building 9, No.18 Kechuang 10th St, BDA, Beijing, 100176
marketing@sinobiological.com
https://www.sinobiological.com86 400-890-9989
headquarters: China
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.
questions and comments